Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback